FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

39207011000001104: Zonisamide 100mg/5ml oral suspension 250 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Dec 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1701621000001110 Zonisamide 100mg/5ml oral suspension 250 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1701641000001117 Zonisamide 100mg/5ml oral suspension 250 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zonisamide 100mg/5ml oral suspension 250 ml Has VMP Zonisamide 100mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Zonisamide 100mg/5ml oral suspension 250 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Zonisamide 100mg/5ml oral suspension 250 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zonisamide 100mg/5ml oral suspension 250 ml Has specific active ingredient Zonisamide true Inferred relationship Existential restriction modifier
Zonisamide 100mg/5ml oral suspension 250 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zonisamide 100mg/5ml oral suspension 250 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Zonisamide 100mg/5ml oral suspension 250 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Desizon 20mg/ml oral suspension (Desitin Pharma Ltd) 250 ml Is a True Zonisamide 100mg/5ml oral suspension 250 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start